Back to User profile » Prof. Dr. Do Young Kim

Papers published by Prof. Dr. Do Young Kim:

Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study

Cho YY, Yu SJ, Lee HW, Kim DY, Kang W, Paik YH, Sung PS, Bae SH, Park SC, Doh YS, Kim KM, Jang ES, Kim IH, Kim W, Kim YJ

Journal of Hepatocellular Carcinoma 2021, 8:613-623

Published Date: 18 June 2021

The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B

Lee HW, Lee HW, Lee JS, Roh YH, Lee H, Kim SU, Park JY, Kim DY, Ahn SH, Kim BK

Journal of Hepatocellular Carcinoma 2021, 8:467-476

Published Date: 25 May 2021

Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion

Han S, Lee HW, Park JY, Kim SU, Kim DY, Ahn SH, Han KH, Seong J, Won JY, Han DH, Kim BK

Journal of Hepatocellular Carcinoma 2020, 7:403-412

Published Date: 17 December 2020

Concomitant food intake does not affect the efficacy of entecavir in chronic hepatitis B patients with virological response: a randomized, multicenter, noninferiority trial

Cho EJ, Yu SJ, Kwon SY, Kim JH, Kim DY, Kim W, Lee JS, Lee JW, Lee YJ, Chae HB, Yoon JH

Drug Design, Development and Therapy 2018, 12:3767-3774

Published Date: 2 November 2018

Baracle® vs Baraclude® for 48 weeks in patients with treatment-naïve chronic hepatitis B: a comparison of efficacy and safety

Kim DY, Kim JH, Tak WY, Yeon JE, Lee JH, Yoon JH, Lee YJ, Lee BS, Han BH, Lee HC

Drug Design, Development and Therapy 2017, 11:3145-3152

Published Date: 31 October 2017

Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib

Lee SH, Kim BK, Kim SU, Park JY, Kim DY, Ahn SH, Han KH

Journal of Hepatocellular Carcinoma 2015, 2:39-47

Published Date: 28 April 2015

Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma

Lee SH, Kim SU, Jang JW, Bae SH, Lee SH, Kim BK, Park JY, Kim DY, Ahn SH, Han KH

OncoTargets and Therapy 2015, 8:347-356

Published Date: 2 February 2015

Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma

Yoo EJ, Shin HS, Kim SU, Joo DJ, Park JY, Choi GH, Kim DY, Ahn SH, Seong J, Koh MJ, Han KH, Chon CY

OncoTargets and Therapy 2013, 6:755-759

Published Date: 21 June 2013